Table 1

Patient diagnosis and duration of cyclosporin A therapy

Patient No/sex/age at onset of uveitis (years)DiagnosisClassification (IUSG)/uni/bilateralityDuration CsA therapy (months)
1/F/3.9JCAPanuveitis/both eyes88.3
2/M/9.2Pars planitisIntermediate uveitis/both eyes52.2
3/M/3.9IdiopathicIntermediate uveitis/both eyes28.3
4/M/3.8Sympathetic ophthalmia Posterior uveitis/both eyes25.0
5/M/5.8Pars planitisIntermediate uveitis/both eyes24.9
6/M/6.7Sympathetic ophthalmia Posterior uveitis/both eyes14.3
7/M/3.0IdiopathicIntermediate uveitis/both eyes14.1
8/M/5.6Pars planitisIntermediate uveitis/both eyes11.7
9/F/2.3JCAPanuveitis/both eyes10.6
10/F/11.4JCAIntermediate uveitis/right eye6.5
11/M/8.6IdiopathicPanuveitis/right eye5.1
12/M/9.3Pars planitisIntermediate uveitis/both eyes4.5
13/F/6.0IdiopathicPosterior uveitis/right eye3.8
14/M/15.2Pars planitisIntermediate uveitis/both eyes3.5
  • IUSG = International Uveitis Study Group; CsA = cyclosporin A; JCA = juvenile chronic arthritis.